University of Bonn
Bonn, 53115, Germany
NCT Number: NCT05208346
The aim of this study is to investigate the postprandial effects of fat content and fatty acid composition of mixed meals on parameters associated with cardiometabolic diseases. Therefore, older subjects with increased risk of cardiometabolic diseases consume 4 mixed meals with 25 or 50 g of either canola or coconut oil. In a postprandial period of 6 hours, outcomes associated with cardiometabolic risk (e.g., triglycerides) are analyzed.
Looking for future studies?
Notify Me60 year–80 year
All sexes
Interventional
Not applicable
Bonn, 53115, Germany
In a crossover design, 30 older men and women with increased risk of cardiometabolic diseases consume 4 mixed meals, enriched with either 25 or 50 g canola or coconut oil. During a postprandial period of 6 hours, parameters of lipid metabolism (e.g., plasma triglycerides), glucose metabolism (e.g., plasma glucose, serum insulin), as well as markers of inflammation (e.g., IL-6), vascular system (e.g., pulse wave velocity) and antioxidant system (e.g., trolox equivalent antioxidative capacity) are analyzed. Furthermore, fatty acid profile, neuropsychologic parameters (e.g., attention), subjective feeling of hunger and satiety, and satiety-associated hormones (e.g., ghrelin) are assessed. Each intervention arm will be separated by a washout period of about 14 days.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Fasting triglycerides in serum: ≥ 150 mg/dl Fasting HDL-Cholesterol in serum: women < 50 mg/dl, men < 40 mg/dl Systolic blood pressure: ≥ 130 mmHg, diastolic blood pressure: ≥ 85 mmHg Fasting glucose in plasma: ≥ 100 mg/dL
Exclusion criteria
Mixed meals enriched with either 25 or 50 g of canola or coconut oil
Time frame: Postprandial period of 6 hours
Measurement of triglycerides (mg/dl)
Time frame: Postprandial period of 6 hours
Measurement of total cholesterol (mg/dl)
Time frame: Postprandial period of 6 hours
Measurement of LDL cholesterol (mg/dl)
Time frame: Postprandial period of 6 hours
Measurement of HDL cholesterol (mg/dl)
Time frame: Postprandial period of 6 hours
Measurement of free fatty acids (mmol/L)
Time frame: Postprandial period of 6 hours
Measurement of glucose (mg/dl)
Time frame: Postprandial period of 6 hours
Measurement of insulin (nmol/L)
Time frame: Postprandial period of 6 hours
Assessment via visual analogue scales (e.g., 0 = not hungry at all, 10 = very hungry)
Time frame: Postprandial period of 6 hours
Measurement of gut hormones associated with hunger and satiety in blood (ghrelin in pg/ml; PYY in pg/ml)
Time frame: Postprandial period of 6 hours
Assessment via validated neuropsychological questionnaires (paper-pencil)
Time frame: Postprandial period of 6 hours
Assessment via the Vicorder device (e.g., measurement of pulse wave velocity in m/s)
Time frame: Postprandial period of 6 hours
Measurement of parameters of inflammation in blood (e.g., IL-6 in pg/ml)
Time frame: Postprandial period of 6 hours
Measurement of parameters of antioxidant system in blood (e.g., TEAC in mmol Trolox equivalents/L)
Time frame: Postprandial period of 6 hours
Analysis of fatty acid profile in serum (e.g., alpha-linolenic acid in µmol/L)
University of Bonn
Other
Acute Effects of Canola Oil Compared With Coconut Oil on Postprandial Metabolism in Women and Men With Increased Risk for Cardiometabolic Diseases
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06461273
Behavior, Body Weight
Newark, New Jersey, United States
View Trial DetailsNCT06186102
Arterial Occlusive Diseases, Arteriosclerosis
Aarhus, Jutland, Denmark
View Trial DetailsNCT04922970
Cardiovascular Diseases, Glucose Metabolism Disorders
Copenhagen, Denmark
View Trial DetailsNCT04748835
Behavior, Behavior, Animal
Dallas, Texas, United States
View Trial Details